PTHS.A - Pelthos Therapeutics Inc
Pelthos Therapeutics Inc
Oppenheimer & Co., Inc.Estimate Revision, Price Target Revision

Year-End Results Highlight Strong Zelsuvmi Launch and Momentum into 2026; Reiterate Outperform and Increase PT to $62

公司
PTHS.A
日期
2026-03-19
分析师
Mr. Jeff M. Jones
页数
13
需要登录
请登录后购买研报或生成音频内容。